Peculiarities of long-COVID-19 and treatment strategy: a clinical case
In the last two years, the world has faced a serious challenge - the emergence of a highly contagious and highly virulent new type of coronavirus - SARS-CoV-2, which causes acute respiratory disease - COVID-19. To date, more than 220 million people worldwide have been infected with SARS-CoV-2 and more than 4 million have died from COVID-19. Many people have already encountered this insidious disease, and there is growing evidence of the health consequences of COVID-19, the so-called "postcCOVID syndrome." The same mechanism of autoimmune inflammation caused by molecular mimicry after COVID-19 is suggested in the cases of Guillain-Barré and Miller-Fischer syndrome. SARS-CoV-2 mimics cross-reactive epitopes that may also be present in the synovial membrane and the immune response against them can cause acute inflammation of the joints.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Unported License.The names and email addresses, indicate to the user the website of the journal, will be used solely for internal technical problems of this journal; they will not be distributed and shared with third parties.